Risk of Death – Talk Bio

Actionable Insights Powered by AI

Gilead’s Magrolimab Linked to Increased Risk of Death in Blood Cancer Patients

10 months ago talkbio0Tagged Clinical Research, Enhance (action), Gilead, Hematologic Neoplasms, Increased, magrolimab, Risk of Death

Gilead, Magrolimab, Blood Cancer, Increased Risk of Death, ENHANCE Study